Drugs / BAY86-5047
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00185341 | Feb 2005 → Feb 2007 | endometriosis | Bayer | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAY86-5047 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00185341 ↗ |
| Known as | BX 471 | ChEMBL registry synonym — accepted as the source's own label CHEMBL232656 ↗ |
| Known as | BX-741 | ChEMBL registry synonym — accepted as the source's own label CHEMBL232656 ↗ |
| Known as | ZK811752 | “CCR1-Antagonist (BAY86-5047, ZK811752)” NCT00185341 ↗ |
| Action | Inhibit | “CCR1 Antagonist” NCT00185341 ↗ |
| Modality | Small molecule | — CHEMBL232656 ↗ |
| Route | Oral | “Given orally” NCT00185341 ↗ |
| Target | CCR1 | “CCR1 Antagonist” NCT00185341 ↗ |